BDX Long Call Strategy
BDX (Becton, Dickinson and Company), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
BDX (Becton, Dickinson and Company) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $52.24B, a trailing P/E of 35.56, a beta of 0.29 versus the broader market, a 52-week range of 127.58648-187.35, average daily share volume of 2.8M, a public-listing history dating back to 1973, approximately 70K full-time employees. These structural characteristics shape how BDX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.29 indicates BDX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 35.56 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. BDX pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on BDX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current BDX snapshot
As of May 15, 2026, spot at $143.49, ATM IV 27.70%, IV rank 30.12%, expected move 7.94%. The long call on BDX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long call structure on BDX specifically: BDX IV at 27.70% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 7.94% (roughly $11.40 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BDX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BDX should anchor to the underlying notional of $143.49 per share and to the trader's directional view on BDX stock.
BDX long call setup
The BDX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BDX near $143.49, the first option leg uses a $145.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BDX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BDX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $145.00 | $3.75 |
BDX long call risk and reward
- Net Premium / Debit
- -$375.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$375.00
- Breakeven(s)
- $148.75
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
BDX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on BDX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$375.00 |
| $31.74 | -77.9% | -$375.00 |
| $63.46 | -55.8% | -$375.00 |
| $95.19 | -33.7% | -$375.00 |
| $126.91 | -11.6% | -$375.00 |
| $158.64 | +10.6% | +$988.66 |
| $190.36 | +32.7% | +$4,161.20 |
| $222.09 | +54.8% | +$7,333.73 |
| $253.81 | +76.9% | +$10,506.26 |
| $285.54 | +99.0% | +$13,678.79 |
When traders use long call on BDX
Long calls on BDX express a bullish thesis with defined risk; traders use them ahead of BDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
BDX thesis for this long call
The market-implied 1-standard-deviation range for BDX extends from approximately $132.09 on the downside to $154.89 on the upside. A BDX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current BDX IV rank near 30.12% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on BDX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BDX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BDX-specific events.
BDX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BDX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BDX alongside the broader basket even when BDX-specific fundamentals are unchanged. Long-premium structures like a long call on BDX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BDX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on BDX?
- A long call on BDX is the long call strategy applied to BDX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With BDX stock trading near $143.49, the strikes shown on this page are snapped to the nearest listed BDX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BDX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the BDX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 27.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$375.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BDX long call?
- The breakeven for the BDX long call priced on this page is roughly $148.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BDX market-implied 1-standard-deviation expected move is approximately 7.94%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on BDX?
- Long calls on BDX express a bullish thesis with defined risk; traders use them ahead of BDX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current BDX implied volatility affect this long call?
- BDX ATM IV is at 27.70% with IV rank near 30.12%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.